Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Squinto Stephen P
Relationship:   Director, 10% Owner
City:   Cheshire
State:   CT
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   238,160    

Indirect Shares

   6,290,493      
Direct Value   $19,437,710    

Indirect Value

   $19,013,945      
Total Shares   6,528,653      
Total Value   $38,451,655      


Alexion Pharmaceuticals Inc $19,437,710 Springworks Therapeutics, Inc. $0 Alexion Pharmaceuticals Inc $19,437,710 Springworks Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Alexion Pharmaceuticals Inc ALXN EVP, Chief Global Ops.... 2014-10-27 106,508 2013-10-28 104,186    Premium*  
            Springworks Therapeutics, Inc. SWTX Director, 10% Owner 2022-05-19 131,652 2022-05-19 6,186,307    Premium*  
* Premium Members only  

Records found :    148         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SWTX Springworks Therapeutics,... Director   –       •       •   2019-09-17 4 B $18.00 $4,950,000 I/I 275,000 7,406,307 2.25 -
ALXN Alexion Pharmaceuticals I... Executive VP   •       –      –    2003-10-02 4 AS $20.01 $100,050 D/D (5,000) 30,077 -
ALXN Alexion Pharmaceuticals I... Executive VP/Head of Research   •       –      –    2003-12-02 4 AS $20.20 $101,000 D/D (5,000) 25,077 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2005-05-02 4 AS $20.32 $1,189,127 D/D (57,343) 4,000 -
ALXN Alexion Pharmaceuticals I... Executive VP/Head of Research   •       –      –    2004-02-09 4 AS $20.58 $102,875 D/D (5,000) 20,476 -
ALXN Alexion Pharmaceuticals I... EVP, Head of Research   •       –      –    2004-11-17 4 AS $20.58 $272,410 D/D (13,125) 28,126 -
ALXN Alexion Pharmaceuticals I... EVP, Research and Development   •       –      –    2011-02-18 4 OE $20.58 $205,800 D/D 10,000 49,637 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2011-03-02 4 OE $20.58 $102,900 D/D 5,000 44,637 0 -
ALXN Alexion Pharmaceuticals I... officerTitle   •       –      –    2006-01-09 4 A $20.72 $82,880 D/D 4,000 8,000 -
ALXN Alexion Pharmaceuticals I... EVP, Head of Research   •       –      –    2004-11-16 4 AS $20.82 $104,915 D/D (5,000) 28,126 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2007-11-05 4 OE $21.00 $702,765 D/D 33,465 48,770 0 -
ALXN Alexion Pharmaceuticals I... Executive VP/Head of Research   •       –      –    2004-05-10 4 AS $21.01 $105,050 D/D (5,000) 15,476 -
ALXN Alexion Pharmaceuticals I... EVP, Global Ops. Officer   •       –      –    2013-04-29 4 OE $22.90 $1,231,027 D/D 36,499 144,961 0 -
ALXN Alexion Pharmaceuticals I... EVP, Global Ops. Officer   •       –      –    2013-07-01 4 OE $22.90 $1,726,762 D/D 44,125 152,587 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2013-08-02 4 OE $22.90 $446,963 D/D 14,125 121,467 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2013-11-04 4 OE $22.90 $446,963 D/D 14,125 118,311 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Global Ops. Officer   •       –      –    2014-02-04 4 OE $22.90 $1,656,469 D/D 28,739 124,455 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2004-12-17 4 AS $25.00 $45,250 D/D (1,810) 26,316 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2004-12-20 4 AS $25.00 $361,995 D/D (14,440) 11,876 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2009-03-11 4 GD $31.67 $62,897 D/D 1,986 31,285 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2009-08-04 4 OE $32.25 $135,450 D/D 4,200 32,451 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2009-03-10 4 S $32.34 $10,316 D/D (319) 33,271 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2009-03-16 4 S $34.25 $93,057 D/D (2,717) 28,568 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2009-01-12 4 S $34.48 $12,930 D/D (375) 26,938 0 -
ALXN Alexion Pharmaceuticals I... EVP & Head of Research   •       –      –    2006-02-15 4 AS $35.00 $175,116 D/D (5,000) 8,000 -
  148  Records found
  1   2   3  4   5   6      
  Page 3 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us